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What impact will this research will have on clinical medicine and how does this research 
add to our knowledge base? 
Acute exacerbations of COPD are one of the commonest causes of emergency hospital 
admission worldwide. Following hospital discharge, people with COPD have significant 
impairments in physical functioning and health related quality of life and have high risk of 
readmission. Pulmonary rehabilitation, a program of care comprising exercise-training and 
education, improves exercise capacity and health related quality of life, and reduces 
readmissions. However patient uptake is low. This trial is the first with the primary aim of 
increasing uptake of post-hospitalization pulmonary rehabilitation. This trial demonstrated 
that a simple patient co-designed education video delivered at hospital discharge did not 
increase referral or uptake rates for post-hospitalization pulmonary rehabilitation. 
 
 
 
Online data supplement 
 
This article has an online data supplement, which is accessible from this issue’s table of 
content online at www.atsjournal.org 
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individual basis, with the period the data is available for individually determined based upon 
each request. 
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ABSTRACT 
 
Rationale: Pulmonary rehabilitation following hospitalizations for exacerbations of chronic 
obstructive pulmonary disease (COPD) improves exercise capacity and health-related quality 
of life, and reduces readmissions. However, post-hospitalization pulmonary rehabilitation 
uptake is low. To date, no trials of interventions to increase uptake have been conducted. 
Objective: Effect of a co-designed education video as an adjunct to usual care on post- 
hospitalization pulmonary rehabilitation uptake. 
Methods: An assessor- and statistician-blinded randomized controlled trial with nested 
qualitative interviews of participants in the intervention group. Participants hospitalized with 
COPD exacerbations were assigned 1:1 to receive either usual care (COPD discharge bundle 
including pulmonary rehabilitation information leaflet) or usual care plus the co-designed 
education video delivered via a handheld tablet device at discharge. Randomization used 
minimization to balance age, sex, forced expiratory volume in 1 second (FEV1) % predicted, 
frailty, transport availability and previous pulmonary rehabilitation experience. 
Measurements and Main Results: The primary outcome was pulmonary rehabilitation uptake 
within 28 days of hospital discharge. 200 patients were recruited with 196 randomized (51% 
female, median (interquartile range) FEV1 % predicted 36(27, 48)). Pulmonary rehabilitation 
uptake was 41% and 34% in the usual care and intervention groups respectively (p=0.37), with 
no differences in secondary (pulmonary rehabilitation referral and completion) or safety 
(readmissions and death) endpoints. Six of the fifteen participants interviewed could not 
recall receiving the video. 
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Conclusion: A co-designed education video delivered at hospital discharge did not improve 
post-hospitalization pulmonary rehabilitation uptake, referral or completion. 
 
 
 
Abstract word count 
 
237 
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INTRODUCTION 
 
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are one of the 
commonest causes of emergency hospital admission, and account for over 50% of healthcare 
costs associated with COPD (1). For patients, exacerbations requiring hospitalization are 
associated with significantly reduced physical activity levels (2), impaired health related 
quality of life (3), skeletal muscle dysfunction (4, 5) and reduced physical functioning (6). 
These consequences increase the risk of readmission, but are potentially amenable to 
treatment with exercise-training (7). 
Pulmonary rehabilitation is a comprehensive, patient-tailored intervention that includes 
exercise-training and education, designed to optimise the physical and psychological well- 
being of people with chronic respiratory disease (8). In the latest iteration of the Cochrane 
systematic review, Puhan and colleagues included 20 randomised controlled trials and 1477 
patients, and found moderate-to-large effects of post-exacerbation pulmonary rehabilitation 
on health-related quality of life and exercise capacity, and moderate quality evidence that 
post-exacerbation pulmonary rehabilitation reduces hospital readmissions (9). Accordingly, 
provision of pulmonary rehabilitation within four weeks of hospital discharge is 
recommended within international pulmonary rehabilitation and COPD guidelines (10-12). 
Despite the evidence base and guideline recommendation, observational data suggest that 
uptake of post-exacerbation pulmonary rehabilitation is low (13, 14). However, a recent 
systematic review was unable to identify any randomized controlled trials of interventions 
that aimed to increase uptake of post-exacerbation pulmonary rehabilitation (15). As 
reported barriers to pulmonary rehabilitation include poor patient engagement with, or lack 
of awareness of, pulmonary rehabilitation (16), we hypothesized that education of patients 
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regarding the benefits of pulmonary rehabilitation might improve uptake. We used 
experience-based co-design (17) to produce a patient education video as a potentially low 
cost and easily implementable intervention with high fidelity. 
The primary objective of the study was to determine whether using such a patient co- 
designed education video as an adjunct to usual care could enhance uptake of pulmonary 
rehabilitation within 28 days of discharge following a hospital admission for acute 
exacerbation of COPD. Some of the results have been previously reported in a conference 
abstract (18). 
 
 
 
 
METHODS 
 
Study design and participants 
 
We conducted a parallel, two-group, assessor- and statistician- blinded, mixed methods, 
randomized controlled trial investigating the effects of a patient education video as an adjunct 
to usual care (delivery of a COPD discharge bundle), with embedded qualitative components. 
The study was approved by the London – City and East Research Ethics Committees 
(14/LO/1740) and registered on the ISRCTN registry (13165073). 
Recruitment took place at Hillingdon Hospital, North West London, United Kingdom between 
February 2015 and May 2018. Details concerning eligibility, inclusion and exclusion criteria 
are detailed in the online supplement. All participants provided written informed consent. 
 
 
 
Randomisation procedure 
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Participants were randomized 1:1 to either the control (COPD discharge bundle) or 
intervention (COPD discharge bundle plus patient education video) with minimization used to 
balance groups according to age, sex, lung function, transport, frailty, and naivety to 
pulmonary rehabilitation. Further details are found in the online data supplement. 
 
 
 
Study interventions 
 
All participants received usual care, comprising delivery of a COPD discharge bundle from a 
specialist respiratory allied health professional (19). This included standardised verbal 
information about pulmonary rehabilitation, supplemented by an information leaflet (see 
online data supplement). The intervention group was also provided with the same COPD 
discharge bundle but were asked to watch a patient co-designed education video. A secure 
internet link with password was also provided to allow access to the video after discharge. 
Further details of the intervention, as well as development of the education video, are 
described in the online data supplement. 
 
 
 
Data collection 
 
Along with a structured history, the following were measured: physical performance using 
four meter gait speed (4MGS) (6), spirometry, MRC dyspnoea score, disease-specific health- 
related quality of life (COPD Assessment Test (CAT) (3)). These were measured on the day of 
hospital discharge and at 90 days following hospital discharge. 
 
 
Qualitative study 
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Using purposive sampling (taking account sex and uptake of pulmonary rehabilitation), topic- 
guided, audio recorded interviews of 15 participants in the intervention group were 
conducted to capture their perspectives about the education video and the research process 
(such as timing of the video). Qualitative interviews were conducted within a week after the 
end of the 90-day follow-up period. 
 
 
Study outcomes 
 
Outcome data were collected by a researcher blinded to treatment allocation, and qualitative 
interviews were conducted by a trained researcher. The primary outcome endpoint was 
percentage uptake of pulmonary rehabilitation within 28 days of hospital discharge within 
each treatment arm. Uptake was defined as documented attendance at a pulmonary 
rehabilitation assessment. 
Secondary outcome endpoints were: 1) pulmonary rehabilitation uptake within 90 days of 
hospital discharge; 2) pulmonary rehabilitation referral rate, defined as the percentage of 
patients in each treatment arm for which a referral was received by the pulmonary 
rehabilitation team within 28 days of hospital discharge; 3) pulmonary rehabilitation 
completion rate, defined as percentage of patients starting pulmonary rehabilitation who 
attended ≥8 pulmonary rehabilitation sessions; 4) pulmonary rehabilitation adherence, 
defined as mean number of PR sessions attended by patients starting pulmonary 
rehabilitation; 5) change in physical performance (4MGS) between the day of discharge and 
90 days post-discharge; 6) change in health related quality of life (CAT) between the day of 
discharge and 90 days post-discharge. Safety endpoints were mortality and hospital 
readmissions with 90 days of hospital discharge. 
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Sample size 
 
In a previous study in the same setting, we demonstrated a post-hospitalisation pulmonary 
rehabilitation uptake of 24% (13). To demonstrate an increase in the primary outcome 
measure from 24% to 45% in the experimental group, 178 patients (89 in each group) were 
required with 80% power at the 5% significance level (MedCalc Software, Ostend, Belgium). 
To account for a potential 10% loss to follow-up, we aimed to recruit 100 participants to each 
group. 
Sample size of the qualitative study was based on the predicted minimum number of 
interviews required to achieve saturation, in other words, the point at which gathering fresh 
data does not generate new theoretical insights (information related to the research question 
and objectives) and is based on the concept of Information Power (20). Based on the work of 
Guest et al (21) saturation of themes is usually reached by the twelfth interview. We therefore 
aimed to recruit a minimum of 12 patients for the qualitative interviews. 
 
 
 
Analysis 
 
Quantitative data analysis was completed by the trial statistician (WB) using Stata version 
 
14.1 (StataCorp LP, Texas, USA). The statistician remained blinded to treatment allocations 
until completion of analysis. The pre-specified primary analysis was by intention to treat. 
Categorical data were presented as percentages, and compared between groups using the 
Pearson X2 test. A p value <0.05 was considered statistically significant. 
Page 9 of 110 
9 
 
 
 
 
Change in physical performance and health related quality of life from hospital discharge to 
90 days post-discharge were compared by trial group using independent samples Student’s t 
test (two-sided) (22). Missing data was handled by multiple imputation; further details are in 
the online data supplement. A pre-planned sensitivity analysis considered patients who were 
naïve to pulmonary rehabilitation at recruitment. 
Qualitative interview data were transcribed verbatim, anonymised and analysed using the 
Framework approach (23). 
 
 
 
 
 
 
RESULTS 
 
Figure 1 shows the trial CONSORT flowchart. We recruited 200 patients and randomized 196. 
The baseline characteristics of the 196 randomized participants randomised are shown in 
Table 1. 
 
 
 
Uptake, referral rate, completion and adherence 
 
Table 2 summarises the results of the primary and major secondary outcomes. Overall uptake 
of pulmonary rehabilitation was 37%, with no difference in uptake between the control (41%) 
and intervention (34%) groups; p=0.370. The Kaplan-Meier curve demonstrated no significant 
between group difference in time to uptake of pulmonary rehabilitation (Figure 2; log rank 
test p=0.490). No between group differences were seen in referral, completion or adherence 
rates (Table 2). 
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Change in health-related quality of life and physical performance 
 
There were clinically and statistically significant improvement in CAT in both groups (Mean 
(standard deviation) change: Intervention: -2.94 (7.68); Control: -4.33 (7.38)) with no 
between group differences (p=0.212); Table 2. Similarly, although 4MGS improved in both 
groups, there were no significant between group differences (Mean (standard deviation) 
change in 4MGS: Intervention: 0.25 (0.26) m/s; Control: 0.23 (0.26) m/s; p=0.568); Table 2. 
The improvements seen in both groups are likely to indicate natural recovery following a 
hospitalization. 
 
 
 
Health Resource Utilisation 
 
During the 90-day follow-up period, the mortality rate was 2% and 1% for the control group 
and intervention groups respectively (p=1.000). All-cause readmission rates for the control 
and intervention groups were 15% and 22% respectively during the 90-day follow-up period. 
(p=0.871). 
 
 
 
Sensitivity analysis 
 
Of the 196 participants randomised, 95 (48%) had no previous pulmonary rehabilitation 
experience before recruitment to the study (PR-naïve). Similar to the overall study population 
data, the intervention had no effect on uptake, referral, or completion rates of post- 
hospitalization pulmonary rehabilitation in PR-naïve participants. Further details are outlined 
in Tables E1 and E2 of the Online Data Supplement. 
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Video intervention perspectives 
 
Of the 15 participants who took part in qualitative interviews, eight participants did not take 
up pulmonary rehabilitation, with six of the seven interviewees who did take up pulmonary 
rehabilitation completing the programme. Six of those interviewed did not recall previously 
seeing the video, despite being in the intervention group. Four of these six did take up PR with 
three completing. None of the interviewed participants used the weblink to access the video 
after hospital discharge. 
Patients who did recall viewing the video thought it well-presented, a good length and that 
the information provided was clear. Most stated it was helpful to see patients with lung 
conditions in the video talking about their experiences and the benefits of rehabilitation: 
“because I know how she feels because I felt exactly the same as she did.” (female, aged 62, 
completer). Seven patients had no prior understanding about pulmonary rehabilitation: “So 
the video showed me you know, what it was about. It is useful, it made it clear what was about 
to happen.” (male, aged 51, completer). Patients also thought the video rather than a leaflet 
or verbal information was a better format for information to be retained: “A video stays in 
your head. You can see the exercises. Piece of paper doesn’t.” (female, aged 62, completer) 
Views were mixed regarding the timing of the delivery of the video. Some participants 
thought it was the right time to show the video (just before discharge from hospital): “I think 
you’ve got to get people whilst they’re in hospital and I think the initial video is the right way 
to do it.” (female, aged 52, decliner). Other participants thought that showing the video in 
hospital was not the best time because patients might be too ill or tired: “What I remember 
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of it… I mean I was in a tiswas at the time as well... You got to be back on your feet to fully 
digest what’s going on” (male, aged 79, decliner). 
Suggestions for improvements were to: include patients using oxygen, include younger 
patients, show a greater variety of exercise equipment including simpler ones used in 
community settings, and emphasise the social aspects of pulmonary rehabilitation. 
Of the eight interviewed participants who declined to take up PR, three could not attend as 
 
they stated they were too unwell (“But I couldn't do nothing like that now. No dear, oh no, I 
 
couldn't do that.” - female, aged 91, decliner) or had other significant comorbidities (“I 
 
declined because I’ve got other health issues at the moment. So, that’s why I declined because 
 
I couldn’t guarantee that I’d be there week in week out.” - female, aged 52, decliner). Two 
participants declined because they thought they were doing enough exercise already: “So, 
people would come to see me, they were quite happy with what I was doing. With the walking 
 
I was doing.” (male, aged 79, decliner). For the three remaining participants who did not take 
 
up PR, one was still working and the times did not suit, one could not attend  as his wife was 
 
unwell, and the other stated they didn’t have transport and it was too far to travel. 
 
 
 
 
 
 
 
DISCUSSION 
 
In this assessor- and statistician- blinded, randomized controlled trial, a patient co-designed 
education video shown on the day of hospital discharge had no effect upon patient uptake of 
post-hospitalization pulmonary rehabilitation. Furthermore, the intervention did not increase 
referral or completion rates. Although a significant proportion were unable to recall watching 
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the video at hospital discharge (suggesting the timing was inappropriate for some), qualitative 
interviews of participants in the intervention group revealed positive feedback regarding the 
education video, with those recalling watching the video making suggestions for 
improvement. 
Despite a strong evidence base to support the benefits of post-hospitalization pulmonary 
rehabilitation (9) and guidelines recommendation (10, 11), observational studies have 
consistently shown low patient uptake and completion. Jones et al demonstrated that only 
30% of patients were referred for early PR post-acute exacerbation of COPD, with less than 
10% of eligible patients completing pulmonary rehabilitation following a hospital admission 
for an exacerbation (13). An analysis of Medicare beneficiaries showed that only 4225 (1.9%) 
of 223,832 individuals hospitalized with acute exacerbation of COPD in 2012 received 
pulmonary rehabilitation within six months of the index hospital admission (14). In a 
retrospective analysis of Veterans Health Administration and Medicare data of patients 
hospitalized with COPD between 2007 - 2011, only 1.5 – 2% were revealed to have attended 
at least one session of pulmonary rehabilitation (24). 
Given that pulmonary rehabilitation is a cornerstone of management in COPD, there have 
been surprisingly few studies that have tried to address this implementation gap. In a 
systematic review of the available evidence on interventions for increasing uptake and 
completion of pulmonary rehabilitation, Jones et al were only able to identify one quasi- 
randomized controlled trial, which was assessed to be at high risk of bias (15). No studies 
were identified in the specific post-hospitalization pulmonary rehabilitation setting (15). In a 
subsequent systematic review, that was not limited to randomized controlled trials, Early and 
colleagues were able to identify five studies that included uptake of pulmonary rehabilitation 
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as an outcome (25). All were conducted in primary care or outpatient settings, and many were 
at high risk of bias due to study design (for example, uncontrolled and controlled before and 
after studies). Again, no interventional studies in the post-hospitalization setting were 
identified (25). 
A strength of the current study was that this was the first randomized controlled trial to test 
an intervention designed to increase uptake of pulmonary rehabilitation in the post- 
exacerbation setting. The trial was adequately powered, with an intention to treat analysis, 
and all participants randomized to the intervention group received the treatment as intended 
at hospital discharge. Both control and intervention groups received best standard care, 
including the provision of a COPD discharge bundle (19) which included an information leaflet 
about post-hospitalization pulmonary rehabilitation. Previous studies have observed that 
effective and consistent delivery of a COPD discharge bundle is associated with an increase in 
pulmonary rehabilitation referrals (19). The outcome assessors were blinded, as was the 
statistician, who was blinded to group allocation throughout data analysis. In addition, the 
trial included a qualitative element which identified potential refinements to the intervention 
content and timing of delivery. 
A further strength relates to the intervention being co-designed by key stakeholders, 
including patients who had previously experienced an acute exacerbation of COPD requiring 
hospitalization. The focus of the intervention was to educate patients about the benefits of 
post-hospitalization pulmonary rehabilitation as poor patient knowledge and engagement 
have consistently been observed to be major barriers to uptake (16, 26, 27). Experience based 
co-design, a quality improvement approach that enables staff and patients (or other service 
users) to co-design services in partnership, was used to develop the intervention. This 
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approach has been previously used in a range of clinical settings in the National Health Service 
(28, 29), including pulmonary rehabilitation (30). The qualitative feedback was positive with 
patients commenting that the video was well presented, a good length and the information 
provided was clear. 
There were several limitations to the study. This was single-center study, using a specific video 
in a particular setting, and therefore the results do not preclude the success of future video 
interventions that might be developed for other settings or delivered at different stages of 
the patient pathway. A proportion of eligible patients did not consent to the research study, 
which reflects the difficulties of recruiting acutely unwell, hospitalised patients into research 
studies, and therefore a potential limitation of the study is the generalisability of the trial 
population. We also observed that a proportion of participants did not attend the face-to- 
face visit at three months. However, data for the primary and main secondary outcome 
measures (pulmonary rehabilitation uptake, referral, completion) were available for all trial 
participants. Missing data for physical performance and health related quality of life measures 
were also imputed. Due to the number lost to follow-up, we were unable to systematically 
collect data on reasons for non-uptake of PR. Another limitation was that we did not formally 
assess for cognitive dysfunction, digital literacy or internet availability at home, which may 
have helped with the interpretation of the study results. 
There were several possible reasons why we did not see an increase in pulmonary 
rehabilitation uptake in the video intervention group. First, the video was provided without 
additional counselling as the intervention was designed to be low cost, easily implementable, 
and not burdensome on staff time. With hindsight, a greater focus on behavioural aspects, 
for example with health coaching (31), may have enhanced the benefits of showing the video. 
Page 16 of 110 
16 
 
 
 
 
Previous studies that have used device-based interventions with minimal counselling have 
also been unsuccessful in changing the behaviour of patients with COPD (32). Second, the 
involvement of key stakeholders in the design of the intervention may have provided 
important education for the staff responsible for referrals and improved their knowledge 
regarding pulmonary rehabilitation, with a positive knock-on effect upon referral rates in both 
control and intervention groups. Evidence to support this was the observation that overall 
referral (70%) and uptake (34%) rates in this study compared favourably with previous data 
from the same setting; Jones et al observed pulmonary rehabilitation referral and uptake 
rates of 31% and 24% respectively despite consistent delivery of a COPD discharge bundle. 
Third, the high pulmonary rehabilitation referral rates in both control and intervention 
settings may reflect the so-called “Hawthorne effect”. In other words, the health care 
professionals responsible for referring to pulmonary rehabilitation may have modified their  
behaviour in response to being observed during the trial. Fourth, the barriers to post- 
hospitalisation pulmonary rehabilitation uptake are complex (16, 33), and the simple 
intervention tested in this trial may not have been able to address all these potential barriers. 
Fifth, we observed significant improvements in physical performance and health-related 
quality of life in both intervention and control groups, which is likely to reflect natural 
recovery from an exacerbation requiring hospitalization. This recovery may have influenced 
the decision of participants to take up pulmonary rehabilitation. Finally, the qualitative 
component of the study highlighted that a proportion of the intervention group (six of fifteen 
of those interviewed) had no recall of seeing the video at hospital discharge. A previous 
observational study showed that 57% of patients awaiting discharge following an 
exacerbation had cognitive impairment, with 20% considered to have pathologic impairment 
of processing speed (34). Cognitive impairment was not formally assessed in this study and 
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so it is unclear whether this impacted on the lack of efficacy of the intervention. Whether 
delivering the video intervention at a later date (for example in the post-discharge period 
rather than on day of hospital discharge), or changing the content of the video might influence 
the results requires further evaluation. 
In this specific trial setting, we were unable to demonstrate an increase in referral or uptake 
rates of post-hospitalization pulmonary rehabilitation with the video intervention. However, 
given the intervention is cheap, easily implementable and not associated with any known 
adverse effects, further studies could be considered to identify potential roles for this 
education video. For example, the video might have value in facilitating the implementation 
and delivery of COPD discharge bundles in settings where this is not the standard of care, or 
as part of a more comprehensive behavioural intervention designed to educate patients, staff 
or carers. 
 
 
 
 
 
 
CONCLUSION 
 
In summary, this assessor- and statistician- blinded, randomized controlled trial 
demonstrated that a patient co-designed education video shown on the day of hospital 
discharge had no effect upon patient uptake of post-hospitalization pulmonary rehabilitation, 
nor on referral or completion rates. Further interventional trials are needed to address the 
low uptake rates of post-hospitalization pulmonary rehabilitation. 
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FIGURE LEGENDS 
 
Figure 1. CONSORT diagram for study flow 
 
 
 
 
Figure 2. Kaplan-Meier curve demonstrating uptake of pulmonary rehabilitation within 28 
days of discharge after hospitalisation for an acute exacerbation of COPD according to group 
allocation 
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TABLES 
 
Table 1. Baseline characteristics for whole group and according to group allocation 
 
Variable Whole group (n=196) 
Intervention group 
(n=98) 
Control group (n=98) p value 
Gender: male (n (%)) 95 (49) 49 (50) 46 (47) 0.668 
Age (years) 69 (11) 70 (11) 68 (11) 0.391 
* † 
FEV1 /FVC 0.53 (0.17) 0.53 (0.16) 0.53 (0.17) 0.757 
* 
FEV1 (% predicted) 36 (27, 48) 38 (28, 49) 34 (26, 47) 0.454 
MRC‡ score 4 (3, 5) 4 (3, 5) 4 (3, 5) 0.791 
BMI§ (kg/m2) 25.5 (21.9, 31.0) 26.2 (22.5, 31.9) 24.9 (21.8, 30.3) 0.285 
Index of multiple 
deprivation 
15170 (7213) 15783 (7508) 14550 (6886) 0.234 
Smoking status: 
never/former/current (n 
(%)) 
 
4 (2) / 138 (70) / 54 (28) 
 
1 (1) / 70 (71) / 27 (28) 
 
3 (3) / 68 (69) / 27 (28) 
 
0.598 
Pack year history (years) 40 (27, 60) 40 (26, 55) 40 (28, 60) 0.562 
Charlson Comorbidity Index 2 (1, 2) 2 (1, 2) 2 (1, 2) 0.926 
Self-reported all-cause 
hospital admissions in 
previous year 
 
1 (0, 2) 
 
1 (0, 2) 
 
1 (0, 2) 
 
0.486 
Self-reported courses of 
antibiotics in previous year 
2 (1, 4) 2 (1, 3) 2 (1, 4) 0.979 
Self-reported courses of 
steroids in previous year 
1 (0, 3) 1 (0, 3) 2 (1, 4) 0.630 
Home oxygen required at 
hospital discharge (n (%)) 
7 (4) 4 (4) 3 (3) 0.684 
Acute non-invasive 
ventilation during 
admission (n (%)) 
 
22 (11) 
 
11 (11) 
 
11 (11) 
 
0.944 
Walking aid required on 
admission (n (%)) 
51 (26) 22 (22) 29 (30) 0.254 
Own transport (n (%)) 116 (59) 56 (57) 60 (61) 0.561 
Living alone (n (%)) 83 (43) 39 (40) 44 (45) 0.470 
Hospital length of stay 
(days) 
3 (1, 6) 3 (2, 7) 2 (1, 5) 0.129 
Previous experience of PRll 
(n (%)) 
101 (52) 50 (51) 51 (52) 0.886 
4MGS**: <0.60 m/s (n (%)) 99 (51) 50 (51) 49 (50) 0.944 
COPD Assessment Test 23 (8) 23 (8) 23 (8) 0.888 
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Data reported as mean (standard deviation) or median (25th centile, 75th centile) unless stated 
otherwise; Independent T-Test (or Mann-Whitney for non-normally distributed data) or Chi- 
Squared test was used to compare groups. 
Abbreviations: * = forced expiratory volume in one second; † = forced vital capacity; ‡ = 
Medical Research Council dyspnoea scale; § = body mass index; ll = pulmonary rehabilitation; 
** = four meter gait speed. 
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Table 2. Referral rate, uptake, completion and adherence to early PR for whole group and 
according to group allocation 
Outcome 
Whole group 
(n=196) 
Intervention 
group (n=98) 
Control group 
(n=98) 
p value 
Primary Outcome     
Uptake of PR* within 
28 days (n (%)) 
 
73 (37) 
 
33 (34) 
 
40 (41) 
 
0.370 
Secondary Outcomes     
Referral to PR received 
within 28 days of 
hospital discharge (n 
(%)) 
 
138 (70) 
 
70 (71) 
 
68 (69) 
 
0.754 
Completion: Proportion 
of those taking up PR 
who complete PR (n 
(%)) 
 
38 (52) 
 
15 (46) 
 
23 (58) 
 
0.305 
Adherence: PR sessions 
completed by those 
taking up PR 
 
9 (6) 
 
8 (6) 
 
10 (6) 
 
0.268 
Uptake of PR within 90 
days (n (%)) 
107 (55) 52 (53) 55 (56) 0.911 
Change in CAT† from 
discharge to 90 days 
-3.6 (7.6) -2.9 (7.7) -4.3 (7.4) 0.212 
Change in 4MGS‡ from 
discharge to 90 days 
(m/s) 
 
0.24 (0.26) 
 
0.25 (0.26) 
 
0.23 (0.26) 
 
0.568 
 
 
Data reported as mean (standard deviation) unless stated otherwise. Independent T-Test or 
Chi-Squared Test were used to compare groups. The pulmonary rehabilitation program offers 
2 supervised sessions per week for 8 weeks (i.e. 16 sessions). 
Abbreviations: * = pulmonary rehabilitation; † = COPD Assessment Test; ‡ = four meter gait 
speed. 
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Figure 1. CONSORT diagram for study flow 
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Figure 2. Kaplan-Meier curve demonstrating uptake of pulmonary rehabilitation within 28 
days of discharge after hospitalisation for an acute exacerbation of COPD according to group 
allocation 
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Video intervention development 
 
Experience-based co-design was used to develop the video intervention tested in this trial. 
First, video-recorded interviews were conducted with patients to understand their 
experiences of pulmonary rehabilitation after an acute exacerbation of chronic obstructive 
pulmonary disease (COPD). One of the key issues raised by patients was insufficient 
information about the components of pulmonary rehabilitation, and the potential benefits for 
themselves. Second, clips which illustrated the key perceptions and experiences raised in the 
interviews (known as ‘touch-points’) were subsequently combined and edited to produce a 
‘touch-points’ video. Third, this edited video was then played at three key stakeholder 
feedback events: 1) patients alone (all patients had experienced a hospitalisation for 
exacerbation of COPD, with some previously undergoing post-hospitalisation pulmonary 
rehabilitation); 2) health care professionals alone (from acute care teams involved in the 
inpatient care of patients with exacerbation of COPD and pulmonary rehabilitation teams); 
3) joint patient and healthcare professional event. From these events, the key priority was to 
develop an education video that would allow real past patients to tell prospective patients 
about the benefits of pulmonary rehabilitation in a visual manner. Patient/staff co-design 
groups were then formed to develop the intervention, how it would be delivered and at 
which point in the patient pathway. A schematic of this process is outlined below (Figure E1). 
The video can now be accessed freely on YouTube: 
(https://www.youtube.com/watch?v=56qcTg1CWnw). 
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Figure E1. Schematic of experience-based co-design process 
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METHODS 
 
Participants 
 
Eligible participants were >40 years of age, hospitalised with either a primary diagnosis of an 
acute exacerbation of COPD or primary diagnosis of pneumonia with a secondary diagnosis 
of acute exacerbation of COPD, eligible for post-hospitalisation pulmonary rehabilitation (able 
to walk five metres independently, Medical Research Council (MRC) score ≥2), living within 
the borough of Hillingdon, and had capacity to consent. Exclusion criteria included significant 
co-morbidities that would make exercise unsafe (e.g. evidence of acute coronary syndrome 
or unstable ischaemic heart disease, severe aortic stenosis, uncontrolled cardiac arrythmia) 
and those receiving palliative care with expectation of death within three months. 
 
 
 
Randomization 
 
Participants were randomised 1:1 to either the control (COPD discharge bundle) or 
intervention (COPD discharge bundle plus patient education video). The allocation sequence 
was computer-generated (Minim), accessed by an administrator independent of the 
recruitment process, trial intervention, outcome assessments, clinical team or study 
researchers. Minimisation was used to balance groups according to age (years: </≥65), sex 
(male/female), forced expiratory volume in one second (FEV1) percentage predicted 
(%predicted: </≥50), transport availability (independent driver with a car: yes/no), physical 
frailty status (four meter gait speed (4MGS): </≥0.6 metres/second (m/s) (6)) and self- 
reported previous experience of pulmonary rehabilitation (yes/no). 
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Intervention 
 
The video was delivered via a handheld tablet device (iPad mini) provided by a researcher 
independent of the clinical, study research or pulmonary rehabilitation teams. Patients in the 
intervention group were also provided with a secure internet link and password so that they 
or relatives could access the education video after discharge from hospital. All patients were 
offered a referral for pulmonary rehabilitation at hospital discharge. Patients were also 
provided with telephone numbers to contact the hospital respiratory or pulmonary 
rehabilitation teams to request a referral after discharge. A referral was generated only with 
patient consent. 
 
 
 
Analysis of missing data 
 
Missing data were explored and reported according to cause. Missing data were assumed to 
have occurred completely at random and were handled by a Markov Chain Monte Carlo 
method, using multiple imputations (10 datasets) using simulations from a Bayesian 
prediction distribution for normal data. Data were assumed to be from a multivariate normal 
and data augmentation was applied to Bayesian inference with missing data. The data were 
log transformed for multiple imputation then anti-logged for the analysis. 
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RESULTS 
 
Sensitivity analysis 
 
The pre-planned sensitivity analysis for patients who were naïve to pulmonary rehabilitation 
(PR-naïve) are included in Table E1 and E2. 
 
 
 
Table E1. Baseline characteristics for all PR-naïve and according to group allocation 
 
Variable All PR-naïve (n=95) 
PR-naïve intervention 
group (n=48) 
PR-naïve control group 
(n=47) 
p value 
Gender: male (n (%)) 39 (41) 21 (44) 18 (38) 0.589 
Age (years) 69 (10) 71 (10) 67 (11) 0.053 
* † 
FEV1 /FVC 0.54 (0.17) 0.54 (0.16) 0.54 (0.17) 0.696 
* 
FEV1 (% predicted) 33 (25, 43) 33.5 (27, 43) 32 (25, 42) 0.739 
MRC‡ score 4 (3, 5) 4 (4, 5) 4 (3, 5) 0.971 
BMI§ (kg/m2) 26.7 (7.1) 26.1 (6.6) 27.3 (7.6) 0.599 
Index of multiple 
deprivation 
15611 (7430) 15981 (7235) 15233 (7684) 0.626 
Smoking status: 
never/former/current (n 
(%)) 
2 (2) / 29 (31) / 
64 (67) 
0 (0) / 13 (27) / 
35 (73) 
2 (4) / 16 (34) / 
29 (62) 
 
0.239 
Pack year history (years) 40 (25, 60) 40 (20, 54) 42.5 (28, 68) 0.350 
Charlson Comorbidity 
Index 
1 (1, 2) 1 (1, 2) 2 (1, 2) 0.459 
Self-reported all-cause 
hospital admissions in 
previous year 
 
1 (0, 2) 
 
1 (0, 2) 
 
1 (0, 2) 
 
0.968 
Self-reported courses of 
antibiotics in previous 
year 
 
2 (1, 5) 
 
2 (1, 3) 
 
2 (1, 6) 
 
0.297 
Self-reported courses of 
steroids in previous year 
2 (0, 3) 1 (0, 3) 2 (0.5, 5) 0.225 
Home oxygen required at 
hospital discharge (n (%)) 
4 (4) 3 (6) 1 (2) 0.334 
Acute non-invasive 
ventilation during 
admission (n (%)) 
 
9 (10) 
 
4 (8) 
 
5 (11) 
 
0.676 
Walking aid required on 
admission (n (%)) 
27 (28) 10 (21) 17 (36) 0.098 
Own transport (n (%)) 29 (31) 16 (33) 13 (28) 0.548 
Living alone (n (%)) 43 (45) 21 (43) 22 (47) 0.765 
Hospital length of stay 
(days) 
3 (2, 7) 4 (2, 7) 3 (1, 5) 0.323 
4MGS**: <0.60 m/s (n (%)) 43 (45) 20 (42) 23 (49) 0.477 
COPD Assessment Test 23 (8) 22 (8) 25 (7) 0.060 
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Data reported as mean (standard deviation) or median (25th centile, 75th centile) unless stated 
otherwise; Independent T-Test (or Mann-Whitney for non-normally distributed data) or Chi- 
Squared test was used to compare groups. 
Abbreviations: * = forced expiratory volume in one second; † = forced vital capacity; ‡ = 
medical research council; § = body mass index; ** = four meter gait speed. 
Table E2. Referral rate, uptake, completion and adherence to early PR for all PR-naïve and 
according to group allocation 
 
Outcome All PR-naïve 
(n=95) 
PR-naïve 
intervention 
group (n=48) 
PR-naïve 
control group 
(n=47) 
p value 
Primary Outcome     
Uptake of PR* within 
28 days (n (%)) 
 
32 (34) 
 
17 (35) 
 
15 (32) 
 
0.347 
Secondary Outcomes     
Referral to PR received 
within 28 days of 
hospital discharge (n 
(%)) 
 
 
60 (63) 
 
 
28 (58) 
 
 
32 (68) 
 
 
0.325 
Completion: Proportion 
of those taking up PR 
who complete PR (n 
(%)) 
 
 
15 (47) 
 
 
8 (47) 
 
 
7 (47) 
 
 
0.804 
Adherence: PR sessions 
completed by those 
taking up PR 
 
9 (6) 
 
10 (6) 
 
8 (6) 
 
0.805 
Uptake of PR within 90 
days (n (%)) 
 
45 (47) 
 
21 (44) 
 
24 (50) 
 
0.616 
Change in CAT† from 
discharge to 90 days 
 
-3.2 (7.5) 
 
-2.4 (8.6) 
 
-3.9 (6.1) 
 
0.320 
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Change in 4MGS‡ from 
discharge to 90 days 
(m/s) 
 
0.24 (0.27) 
 
0.27 (0.28) 
 
0.20 (0.26) 
 
0.227 
Data reported as mean (standard deviation) unless stated otherwise. Independent T-Test or 
Chi-Squared Test were used to compare groups. 
Abbreviations: * = pulmonary rehabilitation; † = COPD Assessment Test; ‡ = four meter gait 
speed. 
 
 
Factors associated with pulmonary rehabilitation uptake 
 
Table E3 shows univariate and multivariate analysis of factors associated with pulmonary 
rehabilitation uptake in those referred for pulmonary rehabilitation. Increasing age was 
associated with increased pulmonary rehabilitation uptake, whilst hospital length of stay ≥ 8 
days was associated with reduced pulmonary rehabilitation uptake. No other patient factors 
were associated with pulmonary rehabilitation uptake, including FEV1 %predicted, MRC 
dyspnoea score, smoking status, BMI, index of multiple deprivation, domiciliary oxygen use, 
four metre gait speed, CAT score, or own transport. 
Table E3: Logistic regression for predictors of referral of early PR following hospitalisation 
for an acute exacerbation of COPD 
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Pulmonary Rehabilitation leaflet 
 
This information leaflet was provided as usual care for all participants recruited to this trial 
prior to discharge from hospital as part of the COPD discharge bundle. 
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What impact will this research will have on clinical medicine and how does this research 
add to our knowledge base? 
Acute exacerbations of COPD are one of the commonest causes of emergency hospital 
 
admission  worldwide.  Following  hospital  discharge,  people  with  COPD  have  significant 
 
impairments in physical functioning and health related quality of life and have high risk of 
 
readmission.   Pulmonary rehabilitation, a program of care comprising exercise-training  and 
 
education,  improves  exercise  capacity  and  health  related  quality  of  life,  and  reduces 
 
readmissions. However patient uptake is low. This trial is the first with the 
 
primary aim of increasing uptake of post-hospitalization pulmonary rehabilitation. This trial 
 
demonstrated  that  a  simple  patient  co-designed  education  video  delivered  at  hospital 
 
discharge  did  not  increase  referral  or  uptake  rates  for  post-hospitalization  pulmonary 
 
rehabilitation. 
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ABSTRACT 
 
Rationale: Pulmonary rehabilitation following hospitalizations for exacerbations 
 
of chronic obstructive pulmonary disease (COPD) improves exercise capacity and health- 
related quality of life, and reduces readmissions. However, post-hospitalization pulmonary 
rehabilitation uptake is low. To date, no trials of interventions to increase uptake have been 
conducted. 
Objective: Effect of a co-designed education video as an adjunct to usual care on post- 
hospitalization pulmonary rehabilitation uptake. 
Methods: An assessor- and statistician-blinded randomized controlled trial with nested 
qualitative interviews of participants in the intervention group. Participants hospitalized with 
COPD exacerbations were assigned 1:1 to receive either usual care (COPD discharge bundle 
including pulmonary rehabilitation information leaflet) or usual care plus the co-designed 
education video delivered via a handheld tablet device at discharge. Randomization used 
minimization to balance age, sex, forced expiratory volume in 1 second (FEV1) % predicted, 
frailty, transport availability and previous pulmonary rehabilitation experience. 
Measurements and Main Results: The primary outcome was pulmonary rehabilitation uptake 
within 28 days of hospital discharge. 200 patients were recruited with 196 randomized (51% 
female, median (interquartile range) FEV1 % predicted 36(27, 48)). Pulmonary rehabilitation 
uptake was 41% and 34% in the usual care and intervention groups respectively (p=0.37), with 
no differences in secondary (pulmonary rehabilitation referral and completion) or safety 
(readmissions and death) endpoints. Six of the fifteen participants interviewed could not 
recall receiving the video. 
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Conclusion: A co-designed education video delivered at hospital discharge did not improve 
post-hospitalization pulmonary rehabilitation uptake, referral or completion. 
 
 
 
Abstract word count 
 
237 
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INTRODUCTION 
 
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are one of the 
commonest causes of emergency hospital admission, and account for over 50% of healthcare 
costs   associated   with   COPD   (1).   For   patients,   exacerbations   requiring 
hospitalization are associated with significantly reduced physical activity levels (2), impaired 
 
health related quality of life (3), skeletal muscle dysfunction (4, 5) and reduced physical 
functioning (6). These consequences increase the risk of readmission, but are potentially 
amenable to treatment with exercise-training (7). 
Pulmonary rehabilitation is a comprehensive, patient-tailored intervention that includes 
exercise-training and education, designed to optimise the physical and psychological well- 
being of people with chronic respiratory disease (8). In the latest iteration of the Cochrane 
systematic review, Puhan and colleagues included 20 randomised controlled trials and 1477 
patients, and found moderate-to-large effects of post-exacerbation pulmonary rehabilitation 
on health-related quality of life and exercise capacity, and moderate quality evidence that 
post-exacerbation pulmonary rehabilitation reduces hospital readmissions (9). Accordingly, 
provision of pulmonary rehabilitation within four weeks of hospital discharge is 
recommended within international pulmonary rehabilitation and COPD guidelines (10-12). 
Despite the evidence base and guideline recommendation, observational data suggest that 
uptake of post-exacerbation pulmonary rehabilitation is low (13, 14). However, a recent 
systematic review was unable to identify any randomized controlled trials of interventions 
that aimed to increase uptake of post-exacerbation pulmonary rehabilitation (15). As 
reported barriers to pulmonary rehabilitation include poor patient engagement with, or lack 
of awareness of, pulmonary rehabilitation (16), we hypothesized that education of patients 
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regarding the benefits of pulmonary rehabilitation might improve uptake. We used 
experience-based co-design (17) to produce a patient education video as a potentially low 
cost and easily implementable intervention with high fidelity. 
The primary objective of the study was to determine whether using such a patient co- 
designed education video as an adjunct to usual care could enhance uptake of pulmonary 
rehabilitation within 28 days of discharge following a hospital admission for acute 
exacerbation of COPD. Some of the results have been previously reported in a conference 
abstract (18). 
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METHODS 
 
Study design and participants 
 
We conducted a parallel, two-group, assessor- and statistician- blinded, mixed methods, 
randomized controlled trial investigating the effects of a patient education video as an adjunct 
to usual care (delivery of a COPD discharge bundle), with embedded qualitative components. 
The study was approved by the London – City and East Research Ethics Committees 
(14/LO/1740) and registered on the ISRCTN registry (13165073). 
Recruitment took place at Hillingdon Hospital, North West London, United Kingdom between 
February 2015 and May 2018. Details concerning eligibility, inclusion and exclusion criteria 
are detailed in the online supplement. All participants provided written informed consent. 
 
 
 
Randomisation procedure 
 
Participants were randomized 1:1 to either the control (COPD discharge bundle) or 
intervention (COPD discharge bundle plus patient education video) with minimization used to 
balance groups according to age, sex, lung function, transport, frailty, and naivety to 
pulmonary rehabilitation. Further details are found in the online data supplement. 
 
 
 
Study interventions 
 
All participants received usual care, comprising delivery of a COPD discharge bundle from a 
specialist respiratory allied health professional (19). This included standardised verbal 
information about pulmonary rehabilitation, supplemented by an information leaflet (see 
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online data supplement). The intervention group was also provided with the same COPD 
discharge bundle but were asked to watch a patient co-designed education video. A secure 
internet link with password was also provided to allow access to the video after discharge. 
Further details of the intervention, as well as development of the education video, are 
described in the online data supplement. 
 
 
 
Data collection 
 
Along with a structured history, the following were measured: physical performance using 
four meter gait speed (4MGS) (6), spirometry, MRC dyspnoea score, disease-specific health- 
related quality of life (COPD Assessment Test (CAT) (3)). These were measured on the day of 
hospital discharge and at 90 days following hospital discharge. 
 
 
Qualitative study 
 
Using purposive sampling (taking account sex and uptake of pulmonary rehabilitation), topic- 
guided, audio recorded interviews of 15 participants in the intervention group were 
conducted to capture their perspectives about the education video and the research process 
(such as timing of the video). Qualitative interviews were conducted within a week after the 
end of the 90-day follow-up period. 
 
 
Study outcomes 
 
Outcome data were collected by a researcher blinded to treatment allocation, and qualitative 
interviews were conducted by a trained researcher. The primary outcome endpoint was 
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percentage uptake of pulmonary rehabilitation within 28 days of hospital discharge within 
each treatment arm. Uptake was defined as documented attendance at a pulmonary 
rehabilitation assessment. 
Secondary outcome endpoints were: 1) pulmonary rehabilitation uptake within 90 days of 
hospital discharge; 2) pulmonary rehabilitation referral rate, defined as the percentage of 
patients in each treatment arm for which a referral was received by the pulmonary 
rehabilitation team within 28 days of hospital discharge; 3) pulmonary rehabilitation 
completion rate, defined as percentage of patients starting pulmonary rehabilitation who 
attended ≥8 pulmonary rehabilitation sessions; 4) pulmonary rehabilitation adherence, 
defined as mean number of PR sessions attended by patients starting pulmonary 
rehabilitation; 5) change in physical performance (4MGS) between the day of discharge and 
90 days post-discharge; 6) change in health related quality of life (CAT) between the day of 
discharge and 90 days post-discharge. Safety endpoints were mortality and hospital 
readmissions with 90 days of hospital discharge. 
 
 
 
Sample size 
 
In a previous study in the same setting, we demonstrated a post-hospitalisation pulmonary 
rehabilitation uptake of 24% (13). To demonstrate an increase in the primary outcome 
measure from 24% to 45% in the experimental group, 178 patients (89 in each group) were 
required with 80% power at the 5% significance level (MedCalc Software, Ostend, Belgium). 
To account for a potential 10% loss to follow-up, we aimed to recruit 100 participants to each 
group. 
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Sample  size  of  the  qualitative  study  was  based  on  the  predicted  minimum  number of 
 
interviews required to achieve saturation, in other words, the point at which gathering fresh 
 
data does not generate new theoretical insights (information related to the research question 
 
and objectives) and is based on the concept of Information Power (20). Based on the work of 
 
Guest et al (21) saturation of themes is usually reached by the twelfth interview. We therefore 
 
aimed to recruit a minimum of 12 patients for the qualitative interviews. 
 
 
 
 
 
Analysis 
 
Quantitative data analysis was completed by the trial statistician (WB) using Stata version 
 
14.1 (StataCorp LP, Texas, USA). The statistician remained blinded to treatment allocations 
until completion of analysis. The pre-specified primary analysis was by intention to treat. 
Categorical data were presented as percentages, and compared between groups using the 
Pearson X2 test. A p value <0.05 was considered statistically significant. 
Change in physical performance and health related quality of life from hospital discharge to 
90 days post-discharge were compared by trial group using independent samples Student’s t 
test (two-sided) (22). Missing data was handled by multiple imputation; further details are in 
the online data supplement. A pre-planned sensitivity analysis considered patients who were 
naïve to pulmonary rehabilitation at recruitment. 
Qualitative interview data were transcribed verbatim, anonymised and analysed using the 
Framework approach (23). 
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RESULTS 
 
Figure 1 shows the trial CONSORT flowchart. We recruited 200 patients and randomized 196. 
The baseline characteristics of the 196 randomized participants randomised are shown in 
Table 1. 
 
 
 
Uptake, referral rate, completion and adherence 
 
Table 2 summarises the results of the primary and major secondary outcomes. Overall uptake 
of pulmonary rehabilitation was 37%, with no difference in uptake between the control (41%) 
and intervention (34%) groups; p=0.370. The Kaplan-Meier curve demonstrated no significant 
between group difference in time to uptake of pulmonary rehabilitation (Figure 2; log rank 
test p=0.490). No between group differences were seen in referral, completion or adherence 
rates (Table 2). 
 
 
 
Change in health-related quality of life and physical performance 
 
There were clinically and statistically significant improvement in CAT in both groups (Mean 
(standard deviation) change: Intervention: -2.94 (7.68); Control: -4.33 (7.38)) with no 
between group differences (p=0.212); Table 2. Similarly, although 4MGS improved in both 
groups, there were no significant between group differences (Mean (standard deviation) 
change in 4MGS: Intervention: 0.25 (0.26) m/s; Control: 0.23 (0.26) m/s; p=0.568); Table 2. 
The improvements seen in both groups are likely to indicate natural recovery following a 
hospitalization. 
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Health Resource Utilisation 
 
During the 90-day follow-up period, the mortality rate was 2% and 1% for the control group 
and intervention groups respectively (p=1.000). All-cause readmission rates for the control 
and intervention groups were 15% and 22% respectively during the 90-day follow-up period. 
(p=0.871). 
 
 
 
Sensitivity analysis 
 
Of the 196 participants randomised, 95 (48%) had no previous pulmonary rehabilitation 
experience before recruitment to the study (PR-naïve). Similar to the overall study population 
data, the intervention had no effect on uptake, referral, or completion rates of post- 
hospitalization pulmonary rehabilitation in PR-naïve participants. Further details are outlined 
in Tables E1 and E2 of the Online Data Supplement. 
 
 
 
Video intervention perspectives 
 
Of the 15 participants who took part in qualitative interviews, eight participants did not take 
up pulmonary rehabilitation, with six of the seven interviewees who did take up pulmonary 
rehabilitation completing the programme. Six of those interviewed did not recall previously 
seeing the video, despite being in the intervention group. Four of these six did take up PR with 
three completing. None of the interviewed participants used the weblink to access the video 
 
after hospital discharge. 
 
Patients who did recall viewing the video thought it well-presented, a good length and that 
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at the time as well... You got to be back 
 
 
the information provided was clear. Most stated it was helpful to see patients with lung 
conditions in the video talking about their experiences and the benefits of rehabilitation: 
“because I know how she feels because I felt exactly the same as she did.” (female, aged 62, 
completer). Seven patients had no prior understanding about pulmonary rehabilitation: “So 
the video showed me you know, what it was about. It is useful, it made it clear what was about 
to happen.” (male, aged 51, completer). Patients also thought the video rather than a leaflet 
or verbal information was a better format for information to be retained: “A video stays in 
your head. You can see the exercises. Piece of paper doesn’t.” (female, aged 62, completer) 
Views were mixed regarding the timing of the delivery of the video. Some participants 
thought it was the right time to show the video (just before discharge from hospital): “I think 
you’ve got to get people whilst they’re in hospital and I think the initial video is the right way 
 
to do it.” (female, aged 52, decliner). Other participants thought that showing the video in 
 
hospital was not the best time because patients might be too ill or tired: “What I remember 
 
of it… I mean I was in  a tiswas on your feet to fully 
 
digest what’s going on” (male, aged 79, decliner). 
 
Suggestions for improvements were to: include patients using oxygen, include younger 
patients, show a greater variety of exercise equipment including simpler ones used in 
community settings, and emphasise the social aspects of pulmonary rehabilitation. 
Of the eight interviewed participants who declined to take up PR, three could not attend as 
they stated they were too unwell (“But I couldn't do nothing like that now. No dear, oh no, I 
couldn't do that.” - female, aged 91, decliner) or had other significant comorbidities (“I 
declined because I’ve got other health issues at the moment. So, that’s why I declined because 
I couldn’t guarantee that I’d be there week in week out.” - female, aged 52, decliner). Two 
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participants declined because they thought they were doing enough exercise already: “So, 
people would come to see me, they were quite happy with what I was doing. With the walking 
I was doing.” (male, aged 79, decliner). For the three remaining participants who did not take 
up PR, one was still working and the times did not suit, one could not attend as his wife was 
unwell, and the other stated they didn’t have transport and it was too far to travel. 
 
 
 
 
 
 
DISCUSSION 
 
In this assessor- and statistician- blinded, randomized controlled trial, a patient co-designed 
education video shown on the day of hospital discharge had no effect upon patient uptake of 
post-hospitalization pulmonary rehabilitation. Furthermore, the intervention did not increase 
referral or completion rates. Although a significant proportion were unable to recall watching 
the video at hospital discharge (suggesting the timing was inappropriate for some), qualitative 
interviews of participants in the intervention group revealed positive feedback regarding the 
education video, with those recalling watching the video making suggestions for 
improvement. 
Despite a strong evidence base to support the benefits of post-hospitalization pulmonary 
rehabilitation (9) and guidelines recommendation (10, 11), observational studies have 
consistently shown low patient uptake and completion. Jones et al demonstrated that only 
30% of patients were referred for early PR post-acute exacerbation of COPD, with less than 
10% of eligible patients completing pulmonary rehabilitation following a hospital admission 
for an exacerbation (13). An analysis of Medicare beneficiaries showed that only 4225 (1.9%) 
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of 223,832 individuals hospitalized with acute exacerbation of COPD in 2012 received 
pulmonary rehabilitation within six months of the index hospital admission (14). In a 
retrospective analysis of Veterans Health Administration and Medicare data of patients 
hospitalized with COPD between 2007 - 2011, only 1.5 – 2% were revealed to have attended 
at least one session of pulmonary rehabilitation (24). 
Given that pulmonary rehabilitation is a cornerstone of management in COPD, 
 
there have been surprisingly few studies that have tried to address this implementation gap.  
In a systematic review of the available evidence on interventions for increasing uptake and 
completion of pulmonary rehabilitation, Jones et al were only able to identify one quasi- 
randomized controlled trial, which was assessed to be at high risk of bias (15). No studies 
were identified in the specific post-hospitalization pulmonary rehabilitation setting (15). In a 
subsequent systematic review, that was not limited to randomized controlled trials, Early 
and colleagues were able to identify five studies that included uptake of pulmonary 
rehabilitation as an outcome (25). All were conducted in primary care or outpatient settings, 
and many were at high risk of bias due to study design (for example, uncontrolled and 
controlled before and after studies). Again, no interventional studies in the post-
hospitalization setting were identified (25). 
A strength of the current study was that this was the first randomized controlled trial to test 
an intervention designed to increase uptake of pulmonary rehabilitation in the post- 
exacerbation setting. The trial was adequately powered, with an intention to treat analysis, 
and all participants randomized to the intervention group received the treatment as intended 
at hospital discharge. Both control and intervention groups received best standard care, 
including the provision of a COPD discharge bundle (19) which included an information leaflet 
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about post-hospitalization pulmonary rehabilitation. Previous studies have observed that 
effective and consistent delivery of a COPD discharge bundle is associated with an increase in 
pulmonary rehabilitation referrals (19). The outcome assessors were blinded, as was the 
statistician, who was blinded to group allocation throughout data analysis. In addition, the 
trial included a qualitative element which identified potential refinements to the intervention 
content and timing of delivery. 
A further strength relates to the intervention being co-designed by key stakeholders, 
including patients who had previously experienced an acute exacerbation of COPD requiring 
hospitalization. The focus of the intervention was to educate patients about the benefits of 
post-hospitalization pulmonary rehabilitation as poor patient knowledge and engagement 
have consistently been observed to be major barriers to uptake (16, 26, 27). Experience based 
co-design, a quality improvement approach that enables staff and patients (or other service 
users) to co-design services in partnership, was used to develop the intervention. This 
approach has been previously used in a range of clinical settings in the National Health Service 
(28, 29), including pulmonary rehabilitation (30). The qualitative feedback was positive with 
patients commenting that the video was well presented, a good length and the information 
provided was clear. 
There were several limitations to the study. This was single-center study, using a specific video 
 
in a particular setting, and therefore the results do not preclude the success of future video 
 
interventions that might be developed for other settings or delivered at different stages of 
 
the patient pathway. A proportion of eligible patients did not consent to the research study, 
 
which reflects the difficulties of recruiting acutely unwell, hospitalised patients into research 
 
studies, and therefore a potential limitation of the study is the generalisability of the trial 
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population. We also observed that a proportion of participants did not attend the face-to- 
 
face visit at three months. However, data for the primary and main secondary outcome 
 
measures (pulmonary rehabilitation uptake, referral, completion) were available for all trial 
 
participants. Missing data for physical performance and health related quality of life measures 
 
were also imputed. Due to the number lost to follow-up, we were unable to systematically 
 
collect data on reasons for non-uptake of PR. Another limitation was that we did not formally 
 
assess for cognitive dysfunction, digital literacy or internet availability at home, which may 
 
have helped with the interpretation of the study results. 
 
 
There were several possible reasons why we did not see an increase in pulmonary 
rehabilitation uptake in the video intervention group. First, the video was provided without 
additional counselling as the intervention was designed to be low cost, easily implementable, 
and not burdensome on staff time. With hindsight, a greater focus on behavioural aspects, 
for example with health coaching (31), may have enhanced the benefits of showing the video. 
Previous studies that have used device-based interventions with minimal counselling have 
also been unsuccessful in changing the behaviour of patients with COPD (32). Second, the 
involvement of key stakeholders in the design of the intervention may have provided 
important education for the staff responsible for referrals and improved their knowledge 
regarding pulmonary rehabilitation, with a positive knock-on effect upon referral rates in both 
control and intervention groups. Evidence to support this was the observation that overall 
referral (70%) and uptake (34%) rates in this study compared favourably with previous data 
from the same setting; Jones et al observed pulmonary rehabilitation referral and uptake 
rates of 31% and 24% respectively despite consistent delivery of a COPD discharge bundle. 
Third, the high pulmonary rehabilitation referral rates in both control and intervention 
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settings may reflect the so-called “Hawthorne effect”. In other words, the health care 
professionals responsible for referring to pulmonary rehabilitation may have modified their 
behaviour in response to being observed during the trial. Fourth, the barriers to post- 
hospitalisation pulmonary rehabilitation uptake are complex (16, 33), and the simple 
intervention tested in this trial may not have been able to address all these potential barriers. 
Fifth, we observed significant improvements in physical performance and health-related 
quality of life in both intervention and control groups, which is likely to reflect natural 
 
recovery from an exacerbation requiring hospitalization. This recovery may have  influenced 
 
the  decision  of  participants  to  take  up  pulmonary  rehabilitation.  Finally,  the qualitative 
 
component of the study highlighted that a proportion of the intervention group (six of fifteen 
of those interviewed) had no recall of seeing the video at hospital discharge. A previous 
observational study showed that 57% of patients awaiting discharge following an 
exacerbation had cognitive impairment, with 20% considered to have pathologic impairment 
of processing speed (34). Cognitive impairment was not formally assessed in this study and 
so it is unclear whether this impacted on the lack of efficacy of the intervention. Whether 
 
dDelivering the video intervention at a later date (for example in the post-discharge period 
 
rather than on day of hospital discharge), or changing the content of the video might have 
 
influenced the current findingsresults requires further evaluation.. 
 
 
In this specific trial setting, we were unable to demonstrate an increase in referral or uptake 
rates of post-hospitalization pulmonary rehabilitation with the video intervention. However, 
given the intervention is cheap, easily implementable and not associated with any known 
adverse effects, further studies could be considered to identify potential roles for this 
education video. For example, the video might have value in facilitating the implementation 
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and delivery of COPD discharge bundles in settings where this is not the standard of care, or 
as part of a more comprehensive behavioural intervention designed to educate patients, staff 
or carers. 
 
 
 
 
 
 
CONCLUSION 
 
In summary, this assessor- and statistician- blinded, randomized controlled trial 
demonstrated that a patient co-designed education video shown on the day of hospital 
discharge had no effect upon patient uptake of post-hospitalization pulmonary rehabilitation, 
nor on referral or completion rates. Further interventional trials are needed to address the 
low uptake rates of post-hospitalization pulmonary rehabilitation. 
Page 19 of 110 
19 
 
 
 
 
ACKNOWLEDGEMENTS 
 
The authors are grateful for the support of the staff of the Harefield Pulmonary Rehabilitation 
Team at the Royal Brompton and Harefield NHS Foundation Trust and Hillingdon Integrated 
Respiratory Service at the Hillingdon Hospitals NHS Foundation Trust. We would particularly 
like to thank the subjects for their participation in this study. 
Page 20 of 110 
20 
 
 
 
 
REFERENCES 
 
1. Britton M. The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir Med 
2003; 97 Suppl C: S71-79. 
2. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and 
hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544. 
3. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. 
Minimum clinically important difference for the COPD Assessment Test: a prospective 
analysis. The lancet Respiratory medicine 2014; 2: 195-203. 
4. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer 
M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its 
relationship with CXCL8 and IGF-I. Thorax 2003; 58: 752-756. 
5. Greening NJ, Harvey-Dunstan TC, Chaplin EJ, Vincent EE, Morgan MD, Singh SJ, Steiner MC. 
Bedside assessment of quadriceps muscle by ultrasound after admission for acute 
exacerbations of chronic respiratory disease. Am J Respir Crit Care Med 2015; 192: 810-816. 
6. Kon SS, Jones SE, Schofield SJ, Banya W, Dickson MJ, Canavan JL, Nolan CM, Haselden BM, Polkey 
MI, Cullinan P, Man WD. Gait speed and readmission following hospitalisation for acute 
exacerbations of COPD: a prospective study. Thorax 2015; 70: 1131-1137. 
7. Jones SE, Barker RE, Nolan CM, Patel S, Maddocks M, Man WDC. Pulmonary rehabilitation in 
patients with an acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis 
2018; 10: S1390-S1399. 
8. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man 
WD-C. An official American Thoracic Society/European Respiratory Society statement: key 
concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: 
e13-e64. 
9. Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following 
exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016; 
12: CD005305. 
10. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man 
WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, 
Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen 
DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, 
Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, 
Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF, Rehabilitation AETFoP. An 
official American Thoracic Society/European Respiratory Society statement: key concepts 
and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-64. 
11. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, Greening NJ, Heslop K, Hull JH, 
Man WD, Morgan MD, Proud D, Roberts CM, Sewell L, Singh SJ, Walker PP, Walmsley S, 
British Thoracic Society Pulmonary Rehabilitation Guideline Development G, British Thoracic 
Society Standards of Care C. British Thoracic Society guideline on pulmonary rehabilitation in 
adults. Thorax 2013; 68 Suppl 2: ii1-30. 
12. Wedzicha JAEC-C, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, Criner GJ, Papi A, 
Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JAAC-C. Management of 
COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. 
Eur Respir J 2017; 49. 
13. Jones SE, Green SA, Clark AL, Dickson MJ, Nolan AM, Moloney C, Kon SS, Kamal F, Godden J, 
Howe C, Bell D, Fleming S, Haselden BM, Man WD. Pulmonary rehabilitation following 
hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax 
2014; 69: 181-182. 
14. Spitzer KA, Stefan MS, Priya A, Pack QR, Pekow PS, Lagu T, Pinto-Plata VM, ZuWallack RL, 
Lindenauer PK. Participation in Pulmonary Rehabilitation after Hospitalization for Chronic 
Page 21 of 110 
21 
 
 
 
 
Obstructive Pulmonary Disease among Medicare Beneficiaries. Ann Am Thorac Soc 2019; 16: 
99-106. 
15. Jones AW, Taylor A, Gowler H, O'Kelly N, Ghosh S, Bridle C. Systematic review of interventions to 
improve patient uptake and completion of pulmonary rehabilitation in COPD. ERJ Open Res 
2017; 3. 
16. Janaudis-Ferreira T, Tansey CM, Harrison SL, Beaurepaire CE, Goodridge D, Bourbeau J, Baltzan 
M. A Qualitative Study to Inform a More Acceptable Pulmonary Rehabilitation Program after 
Acute Exacerbation of COPD. Ann Am Thorac Soc 2019. 
17. Locock L, Robert G, Boaz A, Vougioukalou S, Shuldham C, Fielden J, Ziebland S, Gager M, Tollyfield 
R, Pearcey J. Health Services and Delivery Research. Testing accelerated experience-based 
co-design: a qualitative study of using a national archive of patient experience narrative 
interviews to promote rapid patient-centred service improvement. Southampton (UK): NIHR 
Journals Library 
 
Copyright (c) Queen's Printer and Controller of HMSO 2014. This work was produced by Locock et al. 
under the terms of a commissioning contract issued by the Secretary of State for Health. This 
issue may be freely reproduced for the purposes of private research and study and extracts 
(or indeed, the full report) may be included in professional journals provided that suitable 
acknowledgement is made and the reproduction is not associated with any form of 
advertising. Applications for commercial reproduction should be addressed to: NIHR Journals 
Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating 
Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.; 
2014. 
18. Barker R, Jones S, Banya W, Kon S, Fleming S, Nolan C, Patel S, Clarke S, Walsh J, Wynne S. A 
Video Intervention to Increase Pulmonary Rehabilitation Uptake for Patients Hospitalized 
with Acute Exacerbations of COPD (virtue): A Randomized Controlled Trial. C106 
PULMONARY REHABILITATION: American Thoracic Society; 2019. p. A5723-A5723. 
19. Hopkinson NS, Englebretsen C, Cooley N, Kennie K, Lim M, Woodcock T, Laverty AA, Wilson S, 
Elkin SL, Caneja C, Falzon C, Burgess H, Bell D, Lai D. Designing and implementing a COPD 
discharge care bundle. Thorax 2012; 67: 90-92. 
20. Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided by 
Information Power. Qualitative health research 2016; 26: 1753-1760. 
21. Guest G, Arwen B, Johnson L. How Many Interviews Are Enough? An Experiment with Data 
Saturation and Variability. Field Methods 2006; 18: 58-82. 
22. Field A. Discovering statistics using IBM SPSS statistics. Sage; 2013. 
23. Oliver SR, Rees RW, Clarke-Jones L, Milne R, Oakley AR, Gabbay J, Stein K, Buchanan P, Gyte G. A 
multidimensional conceptual framework for analysing public involvement in health services 
research. Health expectations : an international journal of public participation in health care 
and health policy 2008; 11: 72-84. 
24. Vercammen-Grandjean C, Schopfer DW, Zhang N, Whooley MA. Participation in Pulmonary 
Rehabilitation by Veterans Health Administration and Medicare Beneficiaries After 
Hospitalization for Chronic Obstructive Pulmonary Disease. J Cardiopulm Rehabil Prev 2018; 
38: 406-410. 
25. Early F, Wellwood I, Kuhn I, Deaton C, Fuld J. Interventions to increase referral and uptake to 
pulmonary rehabilitation in people with COPD: a systematic review. Int J Chron Obstruct 
Pulmon Dis 2018; 13: 3571-3586. 
26. Benzo R, Wetzstein M, Neuenfeldt P, McEvoy C. Implementation of physical activity programs 
after COPD hospitalizations: Lessons from a randomized study. Chron Respir Dis 2015; 12: 5- 
10. 
27. Cox NS, Oliveira CC, Lahham A, Holland AE. Pulmonary rehabilitation referral and participation 
are commonly influenced by environment, knowledge, and beliefs about consequences: a 
systematic review using the Theoretical Domains Framework. J Physiother 2017; 63: 84-93. 
Page 22 of 110 
22 
 
 
 
 
28. Locock L, Robert G, Boaz A, Vougioukalou S, Shuldham C, Fielden J, Ziebland S, Gager M, Tollyfield 
R, Pearcey J. Using a national archive of patient experience narratives to promote local 
patient-centered quality improvement: an ethnographic process evaluation of 'accelerated' 
experience-based co-design. J Health Serv Res Policy 2014; 19: 200-207. 
29. Borgstrom E, Barclay S. Experience-based design, co-design and experience-based co-design in 
palliative and end-of-life care. BMJ supportive & palliative care 2019; 9: 60-66. 
30. Williams S, Turner AM, Beadle H. Experience-based co-design to improve a pulmonary 
rehabilitation programme. International journal of health care quality assurance 2019; 32: 
778-787. 
31. Benzo R, Vickers K, Novotny PJ, Tucker S, Hoult J, Neuenfeldt P, Connett J, Lorig K, McEvoy C. 
Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A 
Randomized Study. Am J Respir Crit Care Med 2016; 194: 672-680. 
32. Nolan CM, Maddocks M, Canavan JL, Jones SE, Delogu V, Kaliaraju D, Banya W, Kon SSC, Polkey 
MI, Man WD. Pedometer Step Count Targets during Pulmonary Rehabilitation in Chronic 
Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med 
2017; 195: 1344-1352. 
33. Harrison SL, Robertson N, Apps L, M CS, Morgan MD, Singh SJ. "We are not worthy"-- 
understanding why patients decline pulmonary rehabilitation following an acute 
exacerbation of COPD. Disabil Rehabil 2015; 37: 750-756. 
34. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients 
hospitalized with acute exacerbation of COPD. Chest 2013; 144: 119-127. 
Page 23 of 110 
23 
 
 
 
 
FIGURE LEGENDS 
 
Figure 1. CONSORT diagram for study flow 
 
 
 
 
Figure 2. Kaplan-Meier curve demonstrating uptake of pulmonary rehabilitation within 28 
days of discharge after hospitalisation for an acute exacerbation of COPD according to group 
allocation 
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TABLES 
 
Table 1. Baseline characteristics for whole group and according to group allocation 
Variable Whole group (n=196) 
Intervention group 
(n=98) 
Control group (n=98) p value 
Gender: male (n (%)) 95 (49) 49 (50) 46 (47) 0.668 
Age (years) 69 (11) 70 (11) 68 (11) 0.391 
* † 
FEV1 /FVC 0.53 (0.17) 0.53 (0.16) 0.53 (0.17) 0.757 
* 
FEV1 (% predicted) 36 (27, 48) 38 (28, 49) 34 (26, 47) 0.454 
MRC‡ score 4 (3, 5) 4 (3, 5) 4 (3, 5) 0.791 
BMI§ (kg/m2) 25.5 (21.9, 31.0) 26.2 (22.5, 31.9) 24.9 (21.8, 30.3) 0.285 
Index of multiple 
deprivation 
15170 (7213) 15783 (7508) 14550 (6886) 0.234 
Smoking status: 
never/former/current (n 
(%)) 
 
4 (2) / 138 (70) / 54 (28) 
 
1 (1) / 70 (71) / 27 (28) 
 
3 (3) / 68 (69) / 27 (28) 
 
0.598 
Pack year history (years) 40 (27, 60) 40 (26, 55) 40 (28, 60) 0.562 
Charlson Comorbidity Index 2 (1, 2) 2 (1, 2) 2 (1, 2) 0.926 
Self-reported all-cause 
hospital admissions in 
previous year 
 
1 (0, 2) 
 
1 (0, 2) 
 
1 (0, 2) 
 
0.486 
Self-reported courses of 
antibiotics in previous year 
2 (1, 4) 2 (1, 3) 2 (1, 4) 0.979 
Self-reported courses of 
steroids in previous year 
1 (0, 3) 1 (0, 3) 2 (1, 4) 0.630 
Home oxygen required at 
hospital discharge (n (%)) 
7 (4) 4 (4) 3 (3) 0.684 
Acute non-invasive 
ventilation during 
admission (n (%)) 
 
22 (11) 
 
11 (11) 
 
11 (11) 
 
0.944 
Walking aid required on 
admission (n (%)) 
51 (26) 22 (22) 29 (30) 0.254 
Own transport (n (%)) 116 (59) 56 (57) 60 (61) 0.561 
Living alone (n (%)) 83 (43) 39 (40) 44 (45) 0.470 
Hospital length of stay 
(days) 
3 (1, 6) 3 (2, 7) 2 (1, 5) 0.129 
Previous experience of PRll 
(n (%)) 
101 (52) 50 (51) 51 (52) 0.886 
4MGS**: <0.60 m/s (n (%)) 99 (51) 50 (51) 49 (50) 0.944 
COPD Assessment Test 23 (8) 23 (8) 23 (8) 0.888 
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Data reported as mean (standard deviation) or median (25th centile, 75th centile) unless stated 
otherwise; Independent T-Test (or Mann-Whitney for non-normally distributed data) or Chi- 
Squared test was used to compare groups. 
Abbreviations: * = forced expiratory volume in one second; † = forced vital capacity; ‡ = 
Medical Research Council dyspnoea scale; § = body mass index; ll = pulmonary rehabilitation; 
** = four meter gait speed. 
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Table 2. Referral rate, uptake, completion and adherence to early PR for whole group and 
according to group allocation 
Outcome 
Whole group 
(n=196) 
Intervention 
group (n=98) 
Control group 
(n=98) 
p value 
Primary Outcome     
Uptake of PR* within 
28 days (n (%)) 
 
73 (37) 
 
33 (34) 
 
40 (41) 
 
0.370 
Secondary Outcomes     
Referral to PR received 
within 28 days of 
hospital discharge (n 
(%)) 
 
138 (70) 
 
70 (71) 
 
68 (69) 
 
0.754 
Completion: Proportion 
of those taking up PR 
who complete PR (n 
(%)) 
 
38 (52) 
 
15 (46) 
 
23 (58) 
 
0.305 
Adherence: PR sessions 
completed by those 
taking up PR 
 
9 (6) 
 
8 (6) 
 
10 (6) 
 
0.268 
Uptake of PR within 90 
days (n (%)) 
107 (55) 52 (53) 55 (56) 0.911 
Change in CAT† from 
discharge to 90 days 
-3.6 (7.6) -2.9 (7.7) -4.3 (7.4) 0.212 
Change in 4MGS‡ from 
discharge to 90 days 
(m/s) 
 
0.24 (0.26) 
 
0.25 (0.26) 
 
0.23 (0.26) 
 
0.568 
 
 
Data reported as mean (standard deviation) unless stated otherwise. Independent T-Test or 
Chi-Squared Test were used to compare groups. The pulmonary rehabilitation program offers 
2 supervised sessions per week for 8 weeks (i.e. 16 sessions). 
 
 
Abbreviations: * = pulmonary rehabilitation; † = COPD Assessment Test; ‡ = four meter gait 
speed. 
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Figure 1. CONSORT diagram for study flow 
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Figure 2. Kaplan-Meier curve demonstrating uptake of pulmonary rehabilitation within 28 
days of discharge after hospitalisation for an acute exacerbation of COPD according to group 
allocation 
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Video intervention development 
 
Experience-based co-design was used to develop the video intervention tested in this trial. 
First, video-recorded interviews were conducted with patients to understand their 
experiences of pulmonary rehabilitation after an acute exacerbation of chronic obstructive 
pulmonary disease (COPD). One of the key issues raised by patients was insufficient 
information about the components of pulmonary rehabilitation, and the potential benefits for 
themselves. Second, clips which illustrated the key perceptions and experiences raised in the 
interviews (known as ‘touch-points’) were subsequently combined and edited to produce a 
‘touch-points’ video. Third, this edited video was then played at three key stakeholder 
feedback events: 1) patients alone (all patients had experienced a hospitalisation for 
exacerbation of COPD, with some previously undergoing post-hospitalisation pulmonary 
rehabilitation); 2) health care professionals alone (from acute care teams involved in the 
inpatient care of patients with exacerbation of COPD and pulmonary rehabilitation teams); 3) 
joint patient and healthcare professional event. From these events, the key priority was to 
develop an education video that would allow real past patients to tell prospective patients 
about the benefits of pulmonary rehabilitation in a visual manner. Patient/staff co-design 
groups were then formed to develop the intervention, how it would be delivered and at which 
point in the patient pathway. A schematic of this process is outlined below (Figure E1). The 
video can now be accessed freely on YouTube: 
(https://www.youtube.com/watch?v=56qcTg1CWnw). 
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Figure E1. Schematic of experience-based co-design process 
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METHODS 
 
Participants 
 
Eligible participants were >40 years of age, hospitalised with either a primary diagnosis of an acute 
exacerbation of COPD or primary diagnosis of pneumonia with a secondary diagnosis of acute exacerbation 
of COPD, eligible for post-hospitalisation pulmonary rehabilitation (able to walk five metres independently, 
Medical Research Council (MRC) score ≥2), living within the borough of Hillingdon, and had capacity to 
consent. Exclusion criteria included significant co-morbidities that would make exercise unsafe (e.g. evidence 
of acute coronary syndrome or unstable ischaemic heart disease, severe aortic stenosis, uncontrolled cardiac 
arrythmia) and those receiving palliative care with expectation of death within three months. 
 
 
 
Randomization 
 
Participants were randomised 1:1 to either the control (COPD discharge bundle) or intervention (COPD 
discharge bundle plus patient education video). The allocation sequence was computer-generated (Minim), 
accessed by an administrator independent of the recruitment process, trial intervention, outcome 
assessments, clinical team or study researchers. Minimisation was used to balance groups according to age 
(years: </≥65), sex (male/female), forced expiratory volume in one second (FEV1) percentage predicted 
(%predicted: </≥50), transport availability (independent driver with a car: yes/no), physical frailty status 
(four meter gait speed (4MGS): </≥0.6 metres/second (m/s) (6)) and self-reported previous experience of 
pulmonary rehabilitation (yes/no). 
 
 
 
Intervention 
 
The video was delivered via a handheld tablet device (iPad mini) provided by a researcher independent of 
the clinical, study research or pulmonary rehabilitation teams. Patients in the intervention group were also 
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provided with a secure internet link and password so that they or relatives could access the education video 
after discharge from hospital. All patients were offered a referral for pulmonary rehabilitation at hospital 
discharge. Patients were also provided with telephone numbers to contact the hospital respiratory or 
pulmonary rehabilitation teams to request a referral after discharge. A referral was generated only with 
patient consent. 
 
 
 
Analysis of missing data 
 
Missing data were explored and reported according to cause. Missing data were assumed to have occurred 
completely at random and were handled by a Markov Chain Monte Carlo method, using multiple imputations 
(10 datasets) using simulations from a Bayesian prediction distribution for normal data. Data were assumed 
to be from a multivariate normal and data augmentation was applied to Bayesian inference with missing 
data. The data were log transformed for multiple imputation then anti-logged for the analysis. 
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RESULTS 
 
Sensitivity analysis 
 
The pre-planned sensitivity analysis for patients who were naïve to pulmonary rehabilitation (PR-naïve) are 
included in Table E1 and E2. 
 
 
 
Table E1. Baseline characteristics for all PR-naïve and according to group allocation 
 
Data 
reported 
as mean 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(standard deviation) or median (25th centile, 75th centile) unless stated otherwise; Independent T-Test (or 
Mann-Whitney for non-normally distributed data) or Chi-Squared test was used to compare groups. 
Variable All PR-naïve (n=95) 
PR-naïve intervention 
group (n=48) 
PR-naïve control group 
(n=47) 
p value 
Gender: male (n (%)) 39 (41) 21 (44) 18 (38) 0.589 
Age (years) 69 (10) 71 (10) 67 (11) 0.053 
 FEV */FVC† 1 0.54 (0.17) 0.54 (0.16) 0.54 (0.17) 0.696 
* 
FEV1 (% predicted) 33 (25, 43) 33.5 (27, 43) 32 (25, 42) 0.739 
MRC‡ score 4 (3, 5) 4 (4, 5) 4 (3, 5) 0.971 
BMI§ (kg/m2) 26.7 (7.1) 26.1 (6.6) 27.3 (7.6) 0.599 
Index of multiple 
deprivation 
15611 (7430) 15981 (7235) 15233 (7684) 0.626 
Smoking status: 
never/former/current (n 
(%)) 
2 (2) / 29 (31) / 
64 (67) 
0 (0) / 13 (27) / 
35 (73) 
2 (4) / 16 (34) / 
29 (62) 
 
0.239 
Pack year history (years) 40 (25, 60) 40 (20, 54) 42.5 (28, 68) 0.350 
Charlson Comorbidity 
Index 
1 (1, 2) 1 (1, 2) 2 (1, 2) 0.459 
Self-reported all-cause 
hospital admissions in 
previous year 
 
1 (0, 2) 
 
1 (0, 2) 
 
1 (0, 2) 
 
0.968 
Self-reported courses of 
antibiotics in previous 
year 
 
2 (1, 5) 
 
2 (1, 3) 
 
2 (1, 6) 
 
0.297 
Self-reported courses of 
steroids in previous year 
2 (0, 3) 1 (0, 3) 2 (0.5, 5) 0.225 
Home oxygen required at 
hospital discharge (n (%)) 
4 (4) 3 (6) 1 (2) 0.334 
Acute non-invasive 
ventilation during 
admission (n (%)) 
 
9 (10) 
 
4 (8) 
 
5 (11) 
 
0.676 
Walking aid required on 
admission (n (%)) 
27 (28) 10 (21) 17 (36) 0.098 
Own transport (n (%)) 29 (31) 16 (33) 13 (28) 0.548 
Living alone (n (%)) 43 (45) 21 (43) 22 (47) 0.765 
Hospital length of stay 
(days) 
3 (2, 7) 4 (2, 7) 3 (1, 5) 0.323 
4MGS**: <0.60 m/s (n (%)) 43 (45) 20 (42) 23 (49) 0.477 
COPD Assessment Test 23 (8) 22 (8) 25 (7) 0.060 
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Abbreviations: * = forced expiratory volume in one second; † = forced vital capacity; ‡ = medical research 
council; § = body mass index; ** = four meter gait speed. 
 
 
 
Table E2. Referral rate, uptake, completion and adherence to early PR for all PR-naïve and according to group 
allocation 
Outcome All PR-naïve 
(n=95) 
PR-naïve 
intervention 
group (n=48) 
PR-naïve 
control group 
(n=47) 
p value 
Primary Outcome     
Uptake of PR* within 
28 days (n (%)) 
 
32 (34) 
 
17 (35) 
 
15 (32) 
 
0.347 
Secondary Outcomes     
Referral to PR received 
within 28 days of 
hospital discharge (n 
(%)) 
 
 
60 (63) 
 
 
28 (58) 
 
 
32 (68) 
 
 
0.325 
Completion: Proportion 
of those taking up PR 
who complete PR (n 
(%)) 
 
 
15 (47) 
 
 
8 (47) 
 
 
7 (47) 
 
 
0.804 
Adherence: PR sessions 
completed by those 
taking up PR 
 
9 (6) 
 
10 (6) 
 
8 (6) 
 
0.805 
Uptake of PR within 90 
days (n (%)) 
 
45 (47) 
 
21 (44) 
 
24 (50) 
 
0.616 
Change in CAT† from 
discharge to 90 days 
 
-3.2 (7.5) 
 
-2.4 (8.6) 
 
-3.9 (6.1) 
 
0.320 
Change in 4MGS‡ from 
discharge to 90 days 
(m/s) 
 
0.24 (0.27) 
 
0.27 (0.28) 
 
0.20 (0.26) 
 
0.227 
 
 
Data reported as mean (standard deviation) unless stated otherwise. Independent T-Test or Chi-Squared 
Test were used to compare groups. 
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Abbreviations: * = pulmonary rehabilitation; † = COPD Assessment Test; ‡ = four meter gait speed. 
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Factors associated with pulmonary rehabilitation uptake 
 
 
Table E3 shows univariate and multivariate analysis of factors associated with pulmonary rehabilitation 
 
uptake in those referred for pulmonary rehabilitation. Increasing age was associated with increased 
 
pulmonary rehabilitation uptake, whilst hospital length of stay ≥ 8 days was associated with reduced 
 
pulmonary rehabilitation uptake. No other patient factors were associated with pulmonary rehabilitation 
 
uptake, including FEV1 %predicted, MRC dyspnoea score, smoking status, BMI, index of multiple 
 
deprivation, domiciliary oxygen use, four metre gait speed, CAT score, or own transport. 
 
 
Table E3: Logistic regression for predictors of referral of early PR following hospitalisation for an acute 
 
exacerbation of COPD 
 
 
 
Page 39 of 110 
39 
 
 
For 
Review 
Only 
 
 
Pulmonary Rehabilitation leaflet 
 
This information leaflet was provided as usual care for all participants recruited to this trial 
prior to discharge from hospital as part of the COPD discharge bundle. 
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